Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q2 2024 Earnings Call Transcript August 12, 2024
Y-mAbs Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.2101 EPS, expectations were $-0.13.
Operator: Good morning, and welcome to Y-mAbs Therapeutics Inc.’s Earnings Conference Call for the Second Quarter of 2024. At this time, all participants are in a listen-only mode. Instructions for the question-and-answer session will follow today’s prepared remarks. As a reminder, today’s...
